Supplementary Figure 1 from MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells

Authors :: Andrean L. Simons
Aditya Stanam
Madelyn Espinosa-Cotton
Laurie Love-Homan
Adam T. Koch
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Knockdown of TRIF does not reduce erlotinib-induced IL-6.

Full Text Access

Tools